These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 11892893

  • 1. Comparative antimicrobial spectrum and activity of BMS284756 (T-3811; a desfluoroquinolone) tested against an international collection of staphylococci and enterococci, including in vitro test development and intermethod comparisons.
    Pfaller MA, Beach ML, Gordon KA, Jones RN.
    J Chemother; 2002 Feb; 14(1):13-8. PubMed ID: 11892893
    [Abstract] [Full Text] [Related]

  • 2. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS, Watters AA, Fritsche TR, Jones RN.
    BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR.
    J Antimicrob Chemother; 2009 Dec 18; 64(6):1226-9. PubMed ID: 19833635
    [Abstract] [Full Text] [Related]

  • 4. Activity of macrolides, lincosamines, streptogramins and fluoroquinolones against streptococcus pneumoniae and enterococci isolates from the western hemisphere: example of international surveillance (SENTRY antimicrobial surveillance program )in the development of new drugs.
    Lewis MT, Jones RN.
    Braz J Infect Dis; 2000 Feb 18; 4(1):15-21. PubMed ID: 10788841
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).
    Kirby JT, Mutnick AH, Jones RN, Biedenbach DJ, Pfaller MA.
    Diagn Microbiol Infect Dis; 2002 Aug 18; 43(4):303-9. PubMed ID: 12151191
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2009 Oct 18; 65(2):158-62. PubMed ID: 19748426
    [Abstract] [Full Text] [Related]

  • 11. Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative bacilli.
    Howard W, Biedenbach DJ, Jones RN.
    Clin Microbiol Infect; 2002 Jun 18; 8(6):340-4. PubMed ID: 12084101
    [Abstract] [Full Text] [Related]

  • 12. Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates.
    Streit JM, Fritsche TR, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2004 Feb 18; 48(2):137-43. PubMed ID: 14972384
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
    Streit JM, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Dec 18; 53(4):307-10. PubMed ID: 15922534
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS, Jones RN, Dowzicky MJ, Fritsche TR.
    Diagn Microbiol Infect Dis; 2005 Jul 18; 52(3):203-8. PubMed ID: 16105565
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci.
    Putnam SD, Sader HS, Farrell DJ, Biedenbach DJ, Castanheira M.
    Int J Antimicrob Agents; 2011 Jan 18; 37(1):39-45. PubMed ID: 21075602
    [Abstract] [Full Text] [Related]

  • 17. Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries.
    Jones RN, Fritsche TR, Sader HS, Ross JE.
    Diagn Microbiol Infect Dis; 2007 Oct 18; 59(2):199-209. PubMed ID: 17908617
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
    Biedenbach DJ, Jones RN, Quality Control Working Group.
    Diagn Microbiol Infect Dis; 2001 Dec 18; 41(4):225-8. PubMed ID: 11777665
    [Abstract] [Full Text] [Related]

  • 20. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan 18; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.